Search clinical trials for: imatinib intolerant
Total 2067 results
-
Associazione Italiana Pazienti Leucemia Mieloide...Not yet recruitingChronic Myeloid Leukemia (CML)Italy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
Bristol-Myers SquibbActive, not recruitingLeukemiaFrance, India, United States, Canada, Spain, Italy, Mexico, South Africa, United Kingdom, Korea, Republic of, Russian Federation, Australia, Argentina, Germany, Brazil, Netherlands, Romania, Singapore
-
Bristol-Myers SquibbCompleted
-
Novartis PharmaceuticalsNo longer availableChronic Myelogenous Leukemia (CML)
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedChronic Myeloid LeukaemiaItaly
-
Blueprint Medicines CorporationCompletedGISTUnited States, Korea, Republic of, Netherlands, China, France, Spain, Italy, Belgium, United Kingdom, Singapore, Australia, Canada, Germany, Sweden, Hungary, Austria, Czechia, Poland
-
Blueprint Medicines CorporationCompletedGastrointestinal Stromal Tumors (GIST) | Other Relapsed or Refractory Solid TumorsUnited States, United Kingdom, France, Korea, Republic of, Belgium, Germany, Italy, Netherlands, Poland, Spain
-
Novartis PharmaceuticalsCompletedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveUnited States, Germany, United Kingdom, Italy, France, Switzerland
-
Novartis PharmaceuticalsCompletedHypereosinophilic Syndrome | Chronic Myelogenous Leukemia | Systemic Mastocytosis | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)United States, Poland, Italy, Belgium, Canada, France, Australia, Netherlands, Sweden, Switzerland, United Kingdom, Spain, Korea, Republic of, Austria, Germany, Denmark, Finland, Singapore, Taiwan, Hong Kong, New Zealand, Norway
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Chronic Myelogenous LeukemiaJapan
-
Novartis PharmaceuticalsCompleted
-
Kristen GanjooGlaxoSmithKlineTerminatedGastrointestinal Stromal Tumor (GIST)United States
-
Novartis PharmaceuticalsCompletedLeukemia, Myeloid, ChronicIsrael
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaColombia, Venezuela
-
Novartis PharmaceuticalsCompletedCML | Nilotinib | Imatinib Resistant | Imatinib IntolerantKorea, Republic of
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompleted
-
PfizerCompletedChronic Myelogenous LeukemiaJapan
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal TumorsFrance, Italy, Spain, Germany, Finland
-
Bristol-Myers SquibbWithdrawnAcute Lymphoblastic Leukemia | Chronic Myeloid LeukemiaNetherlands, Italy, United Kingdom, Russian Federation, Poland, Hungary
-
King Faisal Specialist Hospital & Research CenterCompleted
-
PfizerCompletedGastrointestinal Neoplasms, Gastrointestinal Stromal TumorsChina
-
Kanto CML Study GroupEpidemiological and Clinical Research Information NetworkCompletedChronic Myeloid LeukemiaJapan
-
National Cancer Institute (NCI)TerminatedAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
PfizerTerminatedMetastatic Renal Cell CarcinomaPhilippines
-
Novartis PharmaceuticalsApproved for marketing
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Netherlands, Spain, United States, Italy, Canada, France, Germany, Peru, Singapore, United Kingdom, Australia, Sweden, Finland, Israel, Ireland, Denmark, Korea, Republic of, Norway, Austria, South Africa, Switzerland
-
Novartis PharmaceuticalsNo longer availableChronic Myeloid LeukemiaUnited States, Greece, Taiwan, Germany, Switzerland, United Kingdom, Russian Federation, Singapore, Ireland, Belgium, Italy, Spain, France, Netherlands, Korea, Republic of, Lebanon, Brazil, Canada, Turkey, China, Hungary, Denmark, A... and more
-
Novartis PharmaceuticalsNo longer availableChronic Myelogenous LeukemiaCanada
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaJapan
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, ChronicJapan
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Blast CrisisNetherlands, United States, Italy, Austria, Canada, France, Germany, Singapore, Taiwan, United Kingdom, Australia, Korea, Republic of, Philippines, Sweden, Finland, Israel, Belgium, Denmark, Norway, Switzerland
-
Bristol-Myers SquibbCompletedLeukemia, Myeloid, Chronic | Leukemia, Lymphocytic, Acute, L2United States, Canada
-
King Saud UniversityNot yet recruitingPreDiabetes | Marker; Structural
-
Centre of Postgraduate Medical EducationRecruiting
-
Medical University of ViennaBIOGENA GmbHRecruiting
-
Fudan UniversityRecruitingBladder CancerChina
-
Charite University, Berlin, GermanyAlmond Board of CaliforniaRecruiting
-
Mayo ClinicTemple UniversityRecruitingDiabetes | Insulin Resistance | Glucose IntoleranceUnited States
-
Zydus Lifesciences LimitedRecruiting
-
University of Nevada, Las VegasUniversity of Nevada, RenoNot yet recruitingPre Diabetes | At Risk for Type 2 Diabetes MellitusUnited States
-
German Institute of Human NutritionCharite University, Berlin, Germany; Helmholtz Center Munich; Hasso Plattner...RecruitingObesity | Overweight | Type 2 Diabetes | PrediabetesGermany
-
University of SalernoNot yet recruitingCardiovascular Diseases | Dyslipidemias | Lipid Metabolism Disorders | Statin Adverse Reaction
-
University of Colorado, DenverAmerican Diabetes Association; High Plains Research NetworkRecruiting
-
University Hospital Schleswig-HolsteinRecruiting
-
Brigham and Women's HospitalOpen Medicine FoundationNot yet recruiting
-
University of UtahRecruitingDiabetes Mellitus, Type 2 | Insulin Resistance | Glucose Intolerance | Sleep Disturbance | Overweight or Obesity | Insulin SensitivityUnited States
-
University of MinnesotaNot yet recruiting
-
Guang'anmen Hospital of China Academy of Chinese...Guangdong Provincial Hospital of Traditional Chinese Medicine; Hubei Hospital... and other collaboratorsNot yet recruiting